Research progress of visfatin in diabetic retinopathy
10.3980/j.issn.1672-5123.2020.3.17
- VernacularTitle:内脏脂肪素在糖尿病视网膜病变中的研究进展
- Author:
Yi-Nan Shao
1
Author Information
1. 1Baotou Medical College, Inner Mongolia University of Scince & Technology, Baotou 014040, Inner Mongolia Autonomous Region, China; 2Department of Ophthalmology, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China
- Publication Type:Journal Article
- Keywords:
diabetic retinopathy;
visfatin;
biomarkers
- From:
International Eye Science
2020;20(3):485-488
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic retinopathy(DR)is a chronic retinopathy secondary to diabetes that can cause permanent loss of vision in patients with type 1 and type 2 diabetes. The occurrence of DR is associated with retinal microvascular dysfunction, retinal tissue edema, bleeding, and secondary neovascular proliferation. Studies have shown that patients with diabetes have high expression of visfatin in adipose tissue, liver and kidney, and that the factor may be present in retinal tissue, which has a certain regulatory effect on the development of diabetic retinopathy. This review focuses on the relationship between visfatin and diabetic retinopathy.
